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Metabolomic analysis of low and 
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Fai Loke  1,2
The biofilm-forming-capability of Helicobacter pylori has been suggested to be among factors 
influencing treatment outcome. However, H. pylori exhibit strain-to-strain differences in biofilm-
forming-capability. Metabolomics enables the inference of spatial and temporal changes of metabolic 
activities during biofilm formation. Our study seeks to examine the differences in metabolome of low 
and high biofilm-formers using the metabolomic approach. Eight H. pylori clinical strains with different 
biofilm-forming-capability were chosen for metabolomic analysis. Bacterial metabolites were extracted 
using Bligh and Dyer method and analyzed by Liquid Chromatography/Quadrupole Time-of-Flight mass 
spectrometry. The data was processed and analyzed using the MassHunter Qualitative Analysis and 
the Mass Profiler Professional programs. Based on global metabolomic profiles, low and high biofilm-
formers presented as two distinctly different groups. Interestingly, low-biofilm-formers produced 
more metabolites than high-biofilm-formers. Further analysis was performed to identify metabolites 
that differed significantly (p-value < 0.005) between low and high biofilm-formers. These metabolites 
include major categories of lipids and metabolites involve in prostaglandin and folate metabolism. Our 
findings suggest that biofilm formation in H. pylori is complex and probably driven by the bacterium’ 
endogenous metabolism. Understanding the underlying metabolic differences between low and high 
biofilm-formers may enhance our current understanding of pathogenesis, extragastric survival and 
transmission of H. pylori infections.
Bacterial biofilm constitutes of a community of single or multiple species bacteria adhering onto any surface and 
encasing in an exopolysaccharide matrix1–3. The ability of unicellular bacteria to function together as a multicel-
lular population through the formation of biofilm provides survival advantage to the bacterial population as a 
whole2,4 has its merit.
Helicobacter pylori is a bacterial pathogen that has been strongly associated with various gastric diseases 
ranging from chronic gastritis to mucosal-associated lymphoid tissue (MALT) lymphoma and gastric adeno-
carcinoma5. Interestingly, the organism has been demonstrated to form biofilm in vitro6–11. In addition, H. pylori 
biofilm has been demonstrated in the stomach of C57Bl/6J mice6 as well as the human stomach7,10. Furthermore, 
we recently demonstrated that H. pylori has the ability to form biofilm on vegetables, which is a common food 
source for human, potentially plays an important role in its survival and transmission of in the extragastric envi-
ronment12. As biofilm has been demonstrated to decrease susceptibility of the biofilm-forming bacteria to anti-
biotics13,14, controlling and preventing biofilm formation by H. pylori may contribute to successful eradication 
of H. pylori. Recent studies unveiled the complexity the molecular mechanisms underlying H. pylori biofilm 
formation15,16. H. pylori biofilm formation has been found to involve the initiation of multiple mechanisms in 
flagella movement, bacterial virulence, signal transduction and regulation16, and regulated by the combined effect 
of multiple genetic factors15.
Study by Beale et al.17 on the biofilm metabolomics in water distribution revealed that through the analysis of 
the metabolites consumed or excreted as a result of metabolic activities, the biofilm activity could be elucidated. 
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Metabolites are the results of the interaction of the microbial genome with its environment where the metab-
olites are an integral part of any cellular regulatory systems18. In addition, the study of metabolites enables the 
understanding of biofilm developmental process and bacterial molecular components which are important for 
establishing the mutual association of biofilm formation19–22.
Metabolomics has been widely applied to interrogate the free-floating planktonic and adhering biofilm life-
styles of various bacteria such as Acinetobacter baumannii23, Salmonella Typhimurium24, Vibrio fischeri20 and 
Staphylococcus aureus22. Importantly, Booth et al.25 using the metabolomic approach demonstrated that metabolic 
changes in response to copper exposure were found to be significantly different in Pseudomonas fluorescens bio-
films compared to planktonic cultures. However, metabolomic differences between low and high biofilm-forming 
H. pylori have not been investigated. To better understand the factors involved in the biofilm formation of H. 
pylori, this study used the metabolomic approach via liquid chromatography/mass spectrometry (LC/MS). The 
data was then analyzed using MassHunter Qualitative Analysis software to identify the differences between 
metabolomics profiles of low and high biofilm-forming H. pylori clinical strains. We hypothesized that low and 
high biofilm-forming capability of H. pylori under a particular condition is determined by their endogenous 
metabolic capability. In general, biofilm formation could be readily detected by the third day in in-vitro cultures 
of high biofilm-forming H. pylori strains. Hence, in this study, bacterial metabolites of pre-biofilm H. pylori cul-
tures (i.e. day 0 to 3) were analyzed to identify metabolites that may influence the initiation of biofilm formation.
Results
H. pylori biofilm. From our earlier studies, H. pylori clinical strain UM032, UM065, UM066, and UM067 
were shown to be high biofilm-forming strains while UM038, UM054, UM084, and UM114 were low bio-
film-forming strains12,26. The bacterial strains were cultured on chocolate blood agar plates, then the 3-day old H. 
pylori cultures were suspended in broth media for the development of biofilm (i.e. day 0). Biofilm formation was 
observed at the air-liquid interface of cultures of the high biofilm-forming stains but not in the low biofilm-form-
ing stains by day 3. Scanning electron micrographs of the day 3 biofilm of a high biofilm-forming H. pylori strain 
are shown in Supplementary Fig. S1. Based on these findings, the metabolomic study was designed to study the 
differences in bacterial metabolism between high biofilm-forming strains and low biofilm-forming strains from 
day 0 to 3.
Global metabolomics profile. The unsupervised principal component analysis (PCA), which “condenses 
information contained in a large number of original variables into a smaller set of new composite dimensions 
with minimum loss of information”, was for quality control of samples27. When PCA using Euclidean distance 
was applied to compare the global metabolomic profiles (i.e. all molecular features without filtering) of the 8 
individual strains, low and high biofilm-forming H. pylori strains partition into 2 well-separated groups based 
on their distinctive profiles on the PCA plots (Fig. 1A–C). The grouping of these H. pylori strains corresponds to 
their biofilm-forming capability, irrespective of age of culture. Replicates within a group should cluster together. 
On the other hand, the PCA plot generated based on compounds acquired in the negative ionization mode using 
principal components 1 and 3 failed to separate between low and high biofilm formers (Fig. 1D). Hence, clus-
tering pattern shows that separation between low and high biofilm-formers was more differentiated based on 
positively-acquired compounds (Fig. 1A and B) compared to compounds acquired in negative ionization mode 
(Fig. 1C).
Using one-way ANOVA, a total of 1650 molecular features (1454 features were identified in the positive 
ionization mode and 196 features in the negative ionization mode) were identified to be significantly different 
(p-value < 0.005) between low and high biofilm-formers from day 0 to 3. After removing redundant molecular 
features that appeared in both positive and negative lists, 1468 features remained. Notably, 1434 features were 
increased in low biofilm-formers. In contrast, only 34 features were increased in high biofilm-formers. Thus, 
the metabolomes of low biofilm-forming H. pylori were demonstrated to be more diversity compared to high 
biofilm-forming H. pylori. Among these features, 351 features (330 features were increased in low biofilm-formers 
and only 21 features were increased in high biofilm-formers) matched metabolites in the Agilent METLIN 
Accurate Mass-Personal Metabolite Database and Library (AM-PCDL) database based on accurate mass, isotope 
ratios, abundances and spacing The 351 metabolites identified are listed in Supplementary Table S1. The mean 
number of metabolites per sample was 94 (30–176) for the high biofilm forming group and 317 (281–341) for the 
low biofilm forming group. The number of metabolites per low biofilm forming sample was significantly higher 
than the number of metabolites per high biofilm forming sample (p-value < 0.005).
After statistically filtering out non-differential metabolites based on one-way ANNOVAR, metabolites 
acquired using positive and negative ionization modes were combined for further analysis. PCA plots of differ-
ential molecular features show that the metabolomic profiles of high biofilm-formers display a more spread out 
pattern suggesting that they were more heterogeneous in nature (Fig. 2). In contrast, low biofilm-formers, which 
clustered closer together on the PCA plots, were more homogenous. Similarly, the low and high biofilm-formers 
are clearly illustrated as two distinct groups in the heat map by the metabolites that were significantly different 
(p-value < 0.005) (Fig. 3).
Among the 351 metabolites identified, 65 significantly differentiating metabolites were lipids belong-
ing to different categories. The heat map profile (Fig. 3) of these 65 lipids revealed that lipids were enriched 
in low biofilm-formers as compared to the high biofilm-formers. In contrast, few metabolites were increased 
in high biofilm-formers relative to low biofilm-formers. This finding indicates distinct differences between the 
metabolome of low and high biofilm-formers, which is consistent with the PCA plots. The metabolome of low 
biofilm-formers was also more complex than that of high biofilm-formers.
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Biofilm-associated metabolites and pathway analysis. Among metabolites that were enriched 
in low biofilm-formers were 65 lipids of different categories, comprising of 26 glycerophospholipids, 10 
sterol lipids, 7 sphingolipids, 6 fatty acyls, 5 polyketides, 3 prenol lipids, 3 lysophosphatidylethanolamine, 
Figure 1. Two-dimensional principal component analysis (PCA) of 56 samples based on global metabolomic 
profiles. The PCAs were generated using MassHunter Mass Profiler Professional (MPP) software. There were 
28 low and 28 high biofilm-forming samples. Independent replicates are available for Day 1 to 3 samples. Axes 
represent the principle components of the PCA and the numbers indicate the percentage of variance that is 
captured by each component. H. pylori strains formed distinct clusters on the basis of features acquired in 
positive ionization mode using (A) components 1 (20.11%) and 2 (9.39%), and components 1 (20.11%) and 3 
(5.75%) (B). H. pylori strains formed distinct clusters on the basis of molecular features acquired in negative ion 
mode using components 1 (21.25%) and 2 (8.18%) (C) but not when components 1 (21.25%) and 3 (6.2%) was 
used (D). The scores shown by the axes scales are used to check data quality.
Figure 2. Two-dimensional principal component analysis (PCA) based on 351 significantly different 
metabolites. The PCAs were generated using MPP. Legend: red (high biofilm-formers, N = 28) and blue (low 
biofilm-formers, N = 28). Independent replicates are available for Day 1 to 3 samples. Axes represent the first 
three principle components of the PCA and the numbers indicate the percentage of variance that is captured 
by each component. (A) Shows the H. pylori strains separated based on components 1 (61.33%) and 2 (9.15%), 
while (B) shows the strains separated based components 1 (61.33%) and 3 (3.34%).
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2 phosphatidylglycerides, 2 glycerolipids, and a glycosphingolipid (Supplementary Table S2). Notably, 
(24S)-1α,24-dihydroxy-22-oxa-20-epivitamin D3, 16-glutaryloxy-1α,25-dihydroxyvitamin D3, 24-(dimeth-
oxyphosphoryl)-25,26,27-trinorvitamin D3, (22E)-26,26,26,27,27,27-hexafluoro-1α,25-dihydroxy-
22,23-didehydrovitamin D3, and (23S)-23,25-dihydroxy-24-oxovitamin D3 23-(β-glucuronide) are derivatives 
of vitamin D3.
In addition to lipids, non-lipid metabolites were also higher in low biofilm-formers. These include 
5-oxoavermectin “2b” aglycone (KEGG C11954), avermectin B2b monosaccharide (KEGG C11957) and 
avermectin A2b monosaccharide (KEGG C11958), which are involved in the biosynthesis of 12-, 14- and 
16-membered macrolides (map00522). Alkaloids, terpenoids, and triterpene glycosides were increased in low 
biofilm-formers.
Interestingly, N(6)-(octanoyl)lysine, a modified lysine amino acid that is normally found in acyl carrier pro-
tein, was also significantly higher in low biofilm formers (p-value = 6.49E-33). L-arginine (KEGG C00062), 
D-arginine (KEGG C00792) and p-coumaroylputrescine (a metabolite of arginine metabolism; KEGG C18326) 
were mapped to arginine and proline metabolism (map00330) and/or D-arginine and D-ornithine metabolism 
(map00522). Phenylacetaldehyde (KEGG C00601) and Phenylethylamine (KEGG C05332) were mapped to phe-
nyalanine metabolism (map00360). Similarly, lignans (polyphenolic substances derived from phenylalanine) 
were also higher in low biofilm-formers.
Notably, L-Arginine (KEGG C00062), Cilastatin (KEGG C01675) and Neomycin B (KEGG C01737) were 
mapped to antibiotics biosynthesis (map00331, map 00524 and map01130). A sterol lipid, cholic acid glucuronide 
(KEGG C03033) and Indinavir (KEGG C07051) were mapped to bile secretion (map04976). These metabolites 
were also found in the low biofilm-formers but not the high-biofilm formers.
In contrast, 5-methyltetrahydrofolic acid (5-methyl-THF; KEGG: C00440; HMP: HMDB1396) was signifi-
cantly increased in high biofilm-formers by 3.3-fold (p-value = 4.29E-07).
H. pylori J99ΔluxS and J99ΔcagY. H. pylori J99ΔluxS mutant strain was created in the laboratory 
of Associate Professor Hardie Kim at the University of Nottingham while J99ΔcagY mutant strain was gener-
ated as part of another study. Crystal violet assay was performed as described previously12,26. Both J99ΔluxS 
and J99ΔcagY mutant strains were found to have significantly reduced biofilm-forming abilities compared to 
wild-type J99 (p-value < 0.05; indicated by*) (Fig. 4A). Associated with reduced biofilm-forming abilities of the 
mutant strains was the observation of increased number of metabolites produced by the mutant strains compared 
to the isogenic wild-type J99 (p-value < 0.05; indicated by*) (Fig. 4B). Among the metabolites detected in only 
the mutant strains but not found in wild-type J99 was ceramide phosphoinositols (PI-Cer(t18:0/18:0(2OH))) or 
N-(2-hydroxyoctadecanoyl)-4R-hydroxysphinganine-1-phospho-(1′-myo-inositol) (LMP ID LMSP03030037), 
which is a phosphosphingolipid. Interestingly, PI-Cer(t18:0/18:0(2OH)) was high in low biofilm-forming strains 
but low or not detected in high biofilm-forming strains (Fig. 4C).
Discussion
Metabolomics has been employed to investigate the differences between planktonic cultures and biofilms of various 
microbes23,25. This study has taken a step further to utilize metabolomics in distinguishing the metabolomes of H. 
pylori with low and high biofilm-forming capabilities. From day 0 to day 3, both high and low biofilm formers were 
still predominantly in the planktonic form. In contrast, for cultures after day 3, the metabolomic profile of high 
biofilm forming H. pylori is expected to be the combined effects of both planktonic and biofilm bacteria while the 
Figure 3. Heat map and clustering presenting metabolomic profiles of low and high biofilm-formers based on 
65 significantly different lipids. The heat maps and clustering based on Euclidean distance were generated using 
MPP. Features with p-value < 0.005 were considered to be significantly different between low and high biofilm-
formers. Details of these lipids are listed in Suppl. Table S1.
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profile of low biofilm formers is due solely from planktonic bacteria. Therefore, only cultures from day 0 to day 3 
were analyzed in order to minimize the confounding effect of biofilm bacteria in high biofilm formers. Comparative 
metabolomics of pre-biofilm forming cultures from day 0 to day 3 enable the identification of metabolites poten-
tially associated with biofilm initiation and development. Our study showed distinct separation of high from low 
biofilm-formers based on PCA plots and identification of differential metabolites associated with these two groups 
of H. pylori. It also demonstrated the potential of metabolomics for use in the study of biofilm development.
It is not unexpected that low biofilm-formers probably have greater tendency to remain in their free-floating 
planktonic state than high biofilm-formers. The study shows that the low biofilm-forming H. pylori strains pro-
duced larger amount and more diverse types of metabolites indicating higher endogenous metabolic activities 
(especially lipid metabolism) compared to their high biofilm-forming counterparts regardless of age of cultures 
(day 0–3). Consistent with this observation, the inactivation of two genes (luxS and cagY) were demonstrated to 
reduce biofilm forming abilities and associated with increase in type of metabolites detected. Thus, metabolomics 
result in this study suggests that biofilm-forming capability of H. pylori strains may be influenced by the endoge-
nous metabolic activities of the bacterium. It has been proposed earlier by Costerton et al.3 that adhered-bacteria 
(akin to biofilm-formers), are less metabolically active than planktonic bacteria.
The metabolites that were increased in the low biofilm-formers were of different categories of lipids, namely 
glycerophospholipids, sterol lipids, sphingolipids, fatty acyls, polyketides, prenol lipids, lysophosphatidyletha-
nolamine, phosphatidylglycerides, glycerolipids, and glycosphingolipid. It is interesting to note that there has 
been no report of these lipids relating to H. pylori biofilm formation. However, an unpublished study carried out 
earlier in our lab (NUS) found that commercial full cream milk sustained the culturability of H. pylori for longer 
duration than low fat milk at 4 °C. H. pylori spiked into full cream milk remained culturable for as long as 72 hours 
while those in low fat milk completely loss their culturability after 4–8 hours at 4 °C (data not shown). Full cream 
milk contained 2- to 3-fold higher fat content compared to low fat milk. Consistently, BHI broth supplemented 
with fat extracted from milk was found to sustain the culturability of H. pylori for a longer period than just BHI 
alone at 4 °C. These findings indicate that lipids may contribute towards sustaining the viability of H. pylori or 
maintaining the bacterium in its planktonic state. Thus, endogenous biosynthesis of lipids by certain H. pylori 
strains may be associated with low biofilm-formation.
Phospholipids and sphingolipids are important components of cell membranes. These lipids (predominately 
long chain phospholipids and sphingolipids) are increased in low biofilm-formers indicating that the membrane 
of low biofilm-formers may have higher lipid stability and lower membrane fluidity. In addition, sphingolipids 
have previously been reported to inhibit the adherence of Streptococcus mutans to hydroxyapatite surfaces28. 
Hence, it is postulated that the presence of higher abundance of sphingolipids in low biofilm-formers may be 
unfavorable for bacteria-bacteria and bacteria-surface adherence necessary for the initiation of biofilm formation.
Figure 4. (A) Specific biofilm unit of wild-type H. pylori J99, J99ΔluxS and J99ΔcagY determined by 
crystal violet assay. (B) Comparison of number of metabolites detected by LC-MS per sample for H. pylori 
J99, J99ΔluxS and J99ΔcagY. *Represents p-value < 0.05 comparing between wild-type and mutants. (C) 
Comparing the relative abundance of PI-Cer(t18:0/18:0(2OH)) in H. pylori J99, J99ΔluxS, J99ΔcagY, high 
biofilm-forming clinical strains and low biofilm-forming strains.
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It has been established that many lipids (especially fatty acids) may be important in cell signaling that reg-
ulates a wide range of cellular functions29. These signals have been identified in both Gram-positive and 
Gram-negative bacteria as a unique chemical class of quorum sensing signals29. Various bacterial activities, such 
as in intra-species, inter-species and cross-kingdom communications that regulate bacterial growth, virulence, 
motility, polymer production, biofilm development, biofilm dispersion, and persistence, can be linked to fatty 
acid signaling30–33.
N(6)-(Octanoyl)lysine, which participates in the lipoic acid metabolism downstream of fatty acid biosynthe-
sis, was found to be higher in low biofilm-formers. Degradation of acyl carrier protein or of lipoate-derivatized 
proteins will lead to free N(6)-(Octanoyl)lysine. lipoyl(octanoyl) transferase (EC 2.3.1.181). Interestingly, 
Helicobacter pylori has not been shown to posses lipoyl(octanoyl) transferase (EC 2.3.1.181) or lipoyl synthase 
(EC 2.8.1.8). However, it cannot be ruled that other enzyme(s) may perform similar functions to catalyze the 
transfer of endogenously produced octanoic acid from octanoyl-acyl-carrier-protein onto the lipoyl domains of 
lipoate-dependent enzymes.
Myrtucommulone A, a polyketide, was also found to be increased in low biofilm-formers compared to their 
high biofilm-forming counterparts. Myrtucommulone A is a lipophilic carboxylic acid with fatty acid-like char-
acter; they may bind to microsomal prostaglandin E synthase-1 (mPGES-1) as polyunsaturated fatty acids and 
inhibit the pro-tumorigenic prostaglandin E2 (PGE2) synthesis34,35. Prostaglandin is found to be synthesized 
during Candida albicans biofilm formation36,37. The inhibition of prostaglandin synthesis had greatly reduced 
fungal adhesion and detachment of mature biofilm38,39. Although H. pylori does not synthesize prostaglandin, 
it cannot be ruled out that myrtucommulone A synthesis by low biofilm-forming H. pylori strains may inhibit 
gastric prostaglandin synthesis, thereby influencing H. pylori-induced pathogenesis.
Results from the current study showed that biofilm formation in H. pylori may be influenced by its lipidome 
suggesting there may be a difference in membrane composition of low and high biofilm-formers. Notably, it has 
also been suggested that cholesterol may also play a vital role in virulence and contributes to the intrinsic anti-
biotic resistance of H. pylori40. Besides biofilm formation, the lipid composition of bacterial cells has also been 
shown to have an impact on antibiotic susceptibility41, probably due to changes in the penetrance of the mem-
brane to antibiotics. Recently, Yonezawa et al.13 reported that H. pylori biofilm formation increases clarithromycin 
resistance and promotes associated-mutations more frequently than in planktonic cells. Therefore, H. pylori lipid 
biosynthesis pathways should be explored further to better understand the mechanism of antibiotic resistance 
and biofilm formation.
Higher abundance of multiple alkaloids, terpenoids, triterpene glycosides and polyphenolic compounds in 
low biofilm formers spurs our conjecture that these organic compounds may have a role in the initiation of bio-
film formation. Alkaloids are synthesized from terpenoid and polyketide. This conjecture is supported by several 
reports demonstrating that plant and marine compounds with similar structure have anti-biofilm properties42–45. 
Thus, the potential use of phyto compounds to reduce H. pylori biofilm formation should not be overlooked.
5-Methyl THF, is a biologically active form of folic acid which was found to be increased in high 
biofilm-formers. In a nutritional complementation experiment by Lebeer et al.46, the introduction of folic acid 
helped to restore the biofilm-forming ability of luxS knockout mutant of Lactobacillus rhamnosus GG which has 
previously been shown to be defective in biofilm formation. Although eukaryotes are not known to possess the 
luxS gene, antifolates has also been shown to prevent Cryptococcus biofilm formation and inhibit mature biofilm47. 
These studies have highlighted the importance of folate metabolism in both prokaryotic and eukaryotic biofilm 
formation. Therefore, increase of 5-methyl THF in high biofilm-forming H. pylori strains may also demonstrate 
the importance of folate metabolism in H. pylori biofilm formation.
Currently, most of our understanding of bacterial biofilms comes from studying of biofilms cultured using 
established in vitro methods. However, there are expected to be significant differences between biofilms grown in 
the laboratory and in vivo biofilms found in infections. This is the major limitation of this study as the optimized 
laboratory condition for the culturing of H. pylori biofilm is not representative of the complex and dynamic con-
dition of the human stomach or the environment, which is difficult to fully simulate. Thus, the metabolome of in 
vitro H. pylori biofilm may be different from that of biofilm found in the stomach or environment. Nevertheless, 
the findings of this study can form a rational basis for interrogating naturally occurring H. pylori and other bac-
terial biofilms in naturally occurring tissue and environmental samples.
Conclusion
Biofilm formation in H. pylori at the initial growth stage is complex and is probably driven by its endogenous 
metabolism. The metabolism of low and high biofilm-forming H. pylori strains is different metabolically. Studying 
of the underlying metabolic processes that distinguish low and high biofilm-forming H. pylori will enhance our 
understanding of the possible role of biofilm formation in H. pylori pathogenesis, as well as extragastric survival 
and transmission of the organism. In addition, these metabolites may be potential anti-biofilm agents against the 
formation of H. pylori biofilm.
Materials and Methods
Culturing of H. pylori. H. pylori clinical strains used in this study were selected from the collection of the 
Helicobacter Research Laboratory at the University of Malaya (Kuala Lumpur, Malaysia). The biofilm-form-
ing capability of each strain was determined through previous study12,26. Specific biofilm unit is the ratio of the 
absorbance values of crystal violet stained biofilm normalized against OD600 of the growth of corresponding 
planktonic bacteria. Specific biofilm unit was taken to be the amount of biofilm formed by the planktonic bacte-
ria. The highest specific biofilm unit was determined for each of the strains. The bacterial strains were cultured on 
non-selective chocolate blood agar plates supplemented with 7% horse blood (Quad Five, MT, USA). The cultures 
were incubated at 37 °C for up to 3 days in a humidified 10% CO2 incubator (Thermo Scientific, MA, USA).
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Forming of H. pylori biofilm. The 3-day old H. pylori cultures were suspended in brain heart infusion 
(BHI) broth (Oxoid, Hampshire, UK) supplemented with 1% β-cyclodextrin (Sigma-Aldrich, MO, USA) and 
0.4% yeast extract (Oxoid, Hampshire, UK). An aliquot of 10 ml of bacterial suspension containing 107 CFU/ml 
of H. pylori was then inoculated into sterile DURAN® borosilicate glass bottle with screw cap (100 ml; Schott, 
Mainz, Germany) for the development of biofilm. BHI broth without H. pylori served as a negative control. The 
bottles were incubated in a humidified 10% CO2 incubator and monitored at day 0, 1, 2, and 3 for the presence of 
biofilm. The screw caps were left loose during incubation to allow for air circulation. Day 1, 2, and 3 cultures of 
each H. pylori strains were available in independent replicates.
Extraction of metabolites. Biofilm culture was dislodged physically from the wall of the glass bottle and 
mixed with the planktonic culture before harvesting. As biofilm could readily be observed at the air-medium inter-
face of high biofilm-forming strains cultures, this ensures that both representative low and high biofilm-forming 
samples were obtained. The bacterial cultures were harvested and washed 3 times at 10,000 × g for 10 minutes at 
room temperature with BHI broth. The bacterial suspensions were adjusted to OD600 nm of 1.0 in BHI broth and 
0.5 ml of bacterial suspensions were used for metabolite extraction. Bacterial pellets were processed according to 
the modified Bligh and Dyer extraction method48. In brief, 300 µl methanol-chloroform (2:1, v/v) was added to 
each bacterial pellet and vortexed for 1 minute followed by incubation for 1 hour at room temperature. Following 
which, 100 µl of chloroform and 100 µl of water were added to induce phase separation. The extract was left stand-
ing for 10 minutes at room temperature. The mixture was then centrifuged at 10,000 × g for 10 minutes at 4 °C. 
The upper aqueous and lower organic phases were collected and dried in Labconco Refrigerated Centrivap con-
centrator (Kansas City, MO, USA) at 4 °C. The dried samples were subsequently dissolved in 50 μl of acetonitrile/
water (95:5, v/v) and pooled together for LC/MS analysis.
LC/MS profiling of metabolites. Mass spectrometric analysis of the samples was performed on a 1260 
Infinity Quaternary Liquid Chromatography system equipped with a 6540 Quadrupole Time-of-Flight mass 
spectrometer attached to a Dual Agilent Jet Stream Electrospray Ionization (Dual AJS ESI) ionization source 
(Agilent Technologies, CA, USA). Agilent MassHunter LC/MS Data Acquisition software (version B.05.01) was 
used for instrumental control and data collection. The samples were separated using the Agilent Zorbax Eclipse 
plus C18 Rapid Resolution High Throughput separation column (2.1 × 100 mm 1.8 μm) and analyzed in both 
positive and negative modes. In order to obtain a broad coverage of the metabolome, ionization was performed 
in both positive and negative modes. In the positive mode, the mobile phases used were water with 1% formic 
acid (A) and acetonitrile with 0.1% formic acid (B). In negative mode, the mobile phases were water with 1 mM 
ammonium fluoride and 0.1% formic acid (A) and acetonitrile (B). For both modes, a linear gradient was set to 
run from 2% to 98% B over 25 minutes, at 0.5 ml/min. In the event of the run, the injection volume was set at 3 
μl with three injections were made for each sample. A typical sample ESI condition was set at voltage 3.0 kV, gas 
temperature 300 °C, drying gas 8 L/min, nebulizer 35 psig, VCap 3500 V, fragmentor 175 V and skimmer 65 V. The 
instrument was set to acquire over the m/z range of 100–1700 with an acquisition rate of 1 spectra/s. For positive 
ionization mode, two reference masses of (i) 121.0509 m/z and (ii) 922.0098 m/z were measured continuously 
while for negative ionization mode, the reference masses were (i) 112.9855 and (ii) 1033.9881.
Data analysis and statistics. A two-pass feature extraction process was used to find molecular features 
from complex accurate mass data. Raw data was deconvoluted into individual chemical peaks by the MassHunter 
Qualitative Analysis software (Qual; version R.06.00) (Agilent Technologies, CA, USA) for Molecular Feature 
Extraction (MFE), a naïve or “untargeted” data-mining algorithm, which finds groups of co-variant ions for each 
unique feature in a chromatogram. Features with a minimum absolute abundance of 1000 counts within a defined 
mass accuracy (+/−5 ppm) were chosen. The data generated were subsequently imported into the MPP software 
(version B.12.61) for binning, aligning, and creating a consensus for each feature. The second pass used the list of 
consensus features and the “Find by Molecular Formula” algorithm in Qual for “targeted” feature re-extraction. 
This two-pass feature extraction approach improved the quality and accuracy of mass, retention time and abun-
dance values for each candidate feature compared with the MFE only data mining. Finally, the data were imported 
into MPP again for annotation and statistical analysis. Using the baselining option of MPP, the abundance for 
each feature was normalized to the median abundance across all of the samples. Unsupervised principal compo-
nent analysis (PCA) was performed with median centering and scaling to display the inherent variance between 
low and high biofilm-forming groups at different age of cultures. Statistical evaluation of the data was performed 
using one-way ANOVA. A cutoff value of p < 0.005 was considered statistically significant in one-way ANOVA, 
using the Benjamini and Hochberg False Discovery Rate (FDR) set to <1% for multiple testing corrections. 
Identification of the metabolites was done through the IDBrowser function of MPP by matching mined features 
based on accurate mass, isotope ratios, abundances and spacing against metabolites in the AM-PCDL database 
(version 5.0). Further statistical testing was carried out using the IBM SPSS Statistics (version 22) software.
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